Black Rock Inc. Genmab A/S Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GMAB
# of Institutions
237Shares Held
52.6MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY15.1MShares$321 Million0.13% of portfolio
-
Capital International Investors Los Angeles, CA4.42MShares$93.6 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.07MShares$65 Million0.44% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$48.8 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.79MShares$37.8 Million0.07% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.9B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...